1-2 of 2
Lidia Hernandez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potential Synergy of TRAIL with CDK9 Inhibition in Selective Killing of HIV Infected Cell Lines and Primary CD4+ T Cells

David Kotlyar, MD, Constantinos Petrovas, PhD, Arik Cooper, PhD, David Ambrozak, MS, Christina Annunziata, MD PhD, Lidia Hernandez, PhD, Takuya Yamamoto, PhD, Sara Ferrando-Martinez, PhD, Joseph Casazza, MD PhD, Richard Koup, MD
Journal: Blood
Blood (2014) 124 (21): 4142.
https://doi.org/10.1182/blood.V124.21.4142.4142
Published: 2014
Journal Articles

A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression

Christina M. Annunziata, Lidia Hernandez, R. Eric Davis, Adriana Zingone, Laurence Lamy, Lloyd T. Lam, Elaine M. Hurt, Arthur L. Shaffer, W. Michael Kuehl, Louis M. Staudt
Journal: Blood
Blood (2011) 117 (8): 2396–2404.
https://doi.org/10.1182/blood-2010-04-278788
Published: 2011
Includes: Supplemental data